{
    "2020-07-30": [
        [
            {
                "time": "2018-07-26",
                "original_text": "US Indexes Close Mostly Lower Thursday After GDP Report",
                "features": {
                    "keywords": [
                        "Indexes",
                        "Close",
                        "Lower",
                        "GDP",
                        "Report"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "economy"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-08-01",
                "original_text": "Why Eli Lilly Stock Is Down Today",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Stock",
                        "Down",
                        "Today"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-08-01",
                "original_text": "Eli Lilly Stock Falls as Sales Disappoint. Analyst Welcomes Data on Diabetes Drug.",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Stock",
                        "Falls",
                        "Sales",
                        "Disappoint",
                        "Diabetes",
                        "Drug"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-07-31",
                "original_text": "Lilly (LLY) Q2 Earnings Top Estimates, Sales Lag, Stock Down",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Q2",
                        "Earnings",
                        "Top",
                        "Estimates",
                        "Sales",
                        "Lag",
                        "Stock",
                        "Down"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-07-29",
                "original_text": "Eli Lilly Misses Q2 Revenue Forecast, Lifts 2020 Profit Outlook",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Misses",
                        "Q2",
                        "Revenue",
                        "Forecast",
                        "Lifts",
                        "2020",
                        "Profit",
                        "Outlook"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-07-31",
                "original_text": "Eli Lilly (LLY) Q2 Earnings Top Estimates",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Q2",
                        "Earnings",
                        "Top",
                        "Estimates"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-07-31",
                "original_text": "Recap: Eli Lilly Q2 Earnings",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Q2",
                        "Earnings"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-06-01",
                "original_text": "Eli Lilly starts mid-stage study of COVID-19 treatment",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "mid-stage",
                        "study",
                        "COVID-19",
                        "treatment"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2020-07-29",
                "original_text": "Eli Lilly's stock rallies after a profit beat and raised outlook, although revenue fell short",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "stock",
                        "rallies",
                        "profit",
                        "beat",
                        "raised",
                        "outlook",
                        "revenue",
                        "fell",
                        "short"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-07-31",
                "original_text": "Eli Lilly's profit rises 6.4% on diabetes drug strength",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "profit",
                        "rises",
                        "diabetes",
                        "drug",
                        "strength"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-07-29",
                "original_text": "Lilly Reports Second-Quarter Financial Results, Raises EPS Guidance",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Second-Quarter",
                        "Financial",
                        "Results",
                        "Raises",
                        "EPS",
                        "Guidance"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-08-01",
                "original_text": "Jardiance® meets primary endpoint in reducing risk of cardiovascular death or hospitalization for heart failure in phase III trial in adults with and without diabetes",
                "features": {
                    "keywords": [
                        "Jardiance",
                        "primary",
                        "endpoint",
                        "reducing",
                        "risk",
                        "cardiovascular",
                        "death",
                        "hospitalization",
                        "heart",
                        "failure",
                        "phase",
                        "III",
                        "trial",
                        "adults",
                        "diabetes"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}